Polyphor - Articles and news items

Protein targeting antibiotics bring new hope against multi-drug resistance

Industry news / 27 April 2017 / Niamh Marriott, Junior Editor

Polyphor presented promising data for their novel class of antibiotics, the Outer Membrane Protein Targeting Antibiotics (OMPTA)…

Polyphor successfully completes Phase I study with POL6014

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

POL6014 is a highly selective, potent and reversible inhibitor of hNE. Increased levels of hNE is associated with cystic fibrosis…

Polyphor awarded $3 million to advance POL6014 in CF

Industry news / 23 March 2016 / Victoria White

Polyphor’s POL6014 reduces the activity of elastase, an enzyme that destroys lung tissue when it is produced in excess…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+